New York State Common Retirement Fund’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Sell |
|
|||||
|
2025
Q1 | $2.23M | Buy |
|
|||||
|
2024
Q4 | $2.46M | Sell |
|
|||||
|
2024
Q3 | $3.53M | Buy |
|
|||||
|
2024
Q2 | $2.25M | Sell |
|
|||||
|
2024
Q1 | $2.91M | Sell |
|
|||||
|
2023
Q4 | $3.48M | Buy |
|
|||||
|
2023
Q3 | $1.9M | Sell |
|
|||||
|
2023
Q2 | $2.97M | Buy |
|
|||||
|
2023
Q1 | $2.5M | Sell |
|
|||||
|
2022
Q4 | $3.22M | Sell |
|
|||||
|
2022
Q3 | $5.13M | Sell |
|
|||||
|
2022
Q2 | $10.4M | Sell |
|
|||||
|
2022
Q1 | $13.4M | Buy |
|
|||||
|
2021
Q4 | $15.4M | Sell |
|
|||||
|
2021
Q3 | $17.3M | Buy |
|
|||||
|
2021
Q2 | $17.9M | Buy |
|
|||||
|
2021
Q1 | $18M | Buy |
|
|||||
|
2020
Q4 | $20.5M | Buy |
|
|||||
|
2020
Q3 | $10.8M | Buy |
|
|||||
|
2020
Q2 | $10M | Buy |
|
|||||
|
2020
Q1 | $2.19M | Buy |
|
|||||
|
2019
Q4 | $2.1M | Sell |
|
|||||
|
2019
Q3 | $2.46M | Buy |
|
|||||
|
2019
Q2 | $3.56M | Buy |
|
|||||
|
2019
Q1 | $3.67M | Buy |
|
|||||
|
2018
Q4 | $2M | Sell |
|
|||||
|
2018
Q3 | $4.09M | Buy |
|
|||||
|
2018
Q2 | $4.02M | Buy |
|
|||||
|
2018
Q1 | $2.44M | Buy |
|
|||||
|
2017
Q4 | $2M | Sell |
|
|||||
|
2017
Q3 | $3.73M | Hold |
|
|||||
|
2017
Q2 | $4.35M | Buy |
|
|||||
|
2017
Q1 | $4.41M | Buy |
|
|||||
|
2016
Q4 | $4.33M | Hold |
|
|||||
|
2016
Q3 | $4.37M | Hold |
|
|||||
|
2016
Q2 | $3.01M | Sell |
|
|||||
|
2016
Q1 | $4.24M | Buy |
|
|||||
|
2015
Q4 | $6.38M | Buy |
|
|||||
|
2015
Q3 | $4.78M | Buy |
|
|||||
|
2015
Q2 | $2.62M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $213K | Buy |
|